{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:57Z","timestamp":1786119537419,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9,1]]},"DOI":"10.1097\/qai.0b013e3181e53c64","type":"journal-article","created":{"date-parts":[[2010,6,24]],"date-time":"2010-06-24T05:42:51Z","timestamp":1277358171000},"page":"87-94","source":"Crossref","is-referenced-by-count":46,"title":["Genetic Variation of Innate Immune Genes in HIV-Infected African Patients With or Without Oropharyngeal Candidiasis"],"prefix":"10.1097","volume":"55","author":[{"given":"Theo S","family":"Plantinga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar J M","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A","family":"Willment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Ferwerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M D","family":"van de Geer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mecky I N","family":"Matee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Banahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A J","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart-Jan","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon D","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 J A M","family":"van der Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210131","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1086\/339886","article-title":"A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis.","volume":"185","author":"Wozniak","year":"2002","journal-title":"J Infect Dis"},{"key":"R2-12-20210131","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0030-4220(92)90191-R","article-title":"Oral mycoses in HIV infection.","volume":"73","author":"Samaranayake","year":"1992","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"R3-12-20210131","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1600-0714.1989.tb01552.x","article-title":"Oral candidiasis and human immunodeficiency virus infection.","volume":"18","author":"Samaranayake","year":"1989","journal-title":"J Oral Pathol Med"},{"key":"R4-12-20210131","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF02600284","article-title":"A simple clinical staging system that predicts progression to AIDS using CD4 count, oral thrush, and night sweats.","volume":"8","author":"Rabeneck","year":"1993","journal-title":"J Gen Intern Med"},{"key":"R5-12-20210131","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1086\/515006","article-title":"Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.","volume":"27","author":"Martins","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R6-12-20210131","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00002030-200005260-00009","article-title":"Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis.","volume":"14","author":"Arribas","year":"2000","journal-title":"AIDS"},{"key":"R7-12-20210131","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00126334-199905010-00003","article-title":"Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study.","volume":"21","author":"Cauda","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-12-20210131","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20081463","article-title":"Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis.","volume":"206","author":"Conti","year":"2009","journal-title":"J Exp Med"},{"key":"R9-12-20210131","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1128\/IAI.73.11.7458-7464.2005","article-title":"Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae.","volume":"73","author":"Van der Graaf","year":"2005","journal-title":"Infect Immun"},{"key":"R10-12-20210131","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.4049\/jimmunol.172.5.3059","article-title":"The contribution of the Toll-like\/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo.","volume":"172","author":"Bellocchio","year":"2004","journal-title":"J Immunol"},{"key":"R11-12-20210131","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.chom.2009.02.006","article-title":"The macrophage mannose receptor induces IL-17 in response to Candida albicans.","volume":"5","author":"van de Veerdonk","year":"2009","journal-title":"Cell Host Microbe"},{"key":"R12-12-20210131","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrmicro1815","article-title":"An integrated model of the recognition of Candida albicans by the innate immune system.","volume":"6","author":"Netea","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"R13-12-20210131","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2079","article-title":"The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.","volume":"7","author":"ONeill","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"R14-12-20210131","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.4049\/jimmunol.170.7.3451","article-title":"Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling.","volume":"170","author":"Bochud","year":"2003","journal-title":"J Immunol"},{"key":"R15-12-20210131","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/CDLI.11.3.625-626.2004","article-title":"Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients.","volume":"11","author":"Ben-Ali","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"R16-12-20210131","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cyto.2007.12.006","article-title":"Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans.","volume":"41","author":"Woehrle","year":"2008","journal-title":"Cytokine"},{"key":"R17-12-20210131","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2249.2005.03002.x","article-title":"The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram-negative and haematogenous osteomyelitis.","volume":"143","author":"Montes","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"R18-12-20210131","first-page":"29","article-title":"Toll-like receptor 4 Asp299Gly\/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection.","volume":"17","author":"Van der Graaf","year":"2006","journal-title":"Eur Cytokine Netw"},{"key":"R19-12-20210131","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1086\/526500","article-title":"Polymorphisms in toll-like receptor genes and susceptibility to pulmonary Aspergillosis.","volume":"197","author":"Carvalho","year":"2008","journal-title":"J Infect Dis"},{"key":"R20-12-20210131","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/QAD.0b013e32814e6b2d","article-title":"The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania.","volume":"21","author":"Ferwerda","year":"2007","journal-title":"AIDS"},{"key":"R21-12-20210131","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1056\/NEJMoa0901053","article-title":"Human dectin-1 deficiency and mucocutaneous fungal infections.","volume":"361","author":"Ferwerda","year":"2009","journal-title":"N Engl J Med"},{"key":"R22-12-20210131","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/ng1976","article-title":"A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis.","volume":"39","author":"Khor","year":"2007","journal-title":"Nat Genet"},{"key":"R23-12-20210131","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature02451","article-title":"Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.","volume":"429","author":"Saleh","year":"2004","journal-title":"Nature"},{"key":"R24-12-20210131","first-page":"1","article-title":"Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.","volume":"41","author":"Castro","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"R25-12-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0528.1980.tb01249.x","article-title":"Guide to epidemiology and diagnosis of oral mucosal diseases and conditions. World Health Organization.","volume":"8","author":"Kramer","year":"1980","journal-title":"Community Dent Oral Epidemiol"},{"key":"R26-12-20210131","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00002030-199006000-00001","article-title":"Application of flow cytometry to the study of HIV infection.","volume":"4","author":"Landay","year":"1990","journal-title":"AIDS"},{"key":"R27-12-20210131","doi-asserted-by":"crossref","first-page":"43818","DOI":"10.1074\/jbc.M107715200","article-title":"Characterization of the human beta -glucan receptor and its alternatively spliced isoforms.","volume":"276","author":"Willment","year":"2001","journal-title":"J Biol Chem"},{"key":"R28-12-20210131","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1600-0714.1989.tb01355.x","article-title":"High levels of oral yeasts in early HIV-1 infection.","volume":"18","author":"Tylenda","year":"1989","journal-title":"J Oral Pathol Med"},{"key":"R29-12-20210131","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/JCM.40.2.341-350.2002","article-title":"Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals.","volume":"40","author":"Vargas","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R30-12-20210131","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/503116","article-title":"Spread of an inactive form of caspase-12 in humans is due to recent positive selection.","volume":"78","author":"Xue","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R31-12-20210131","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.4049\/jimmunol.175.4.2534","article-title":"Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease.","volume":"175","author":"Schroder","year":"2005","journal-title":"J Immunol"},{"key":"R32-12-20210131","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1073\/pnas.0506803102","article-title":"Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria.","volume":"103","author":"Mockenhaupt","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-12-20210131","doi-asserted-by":"crossref","first-page":"16645","DOI":"10.1073\/pnas.0704828104","article-title":"TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans.","volume":"104","author":"Ferwerda","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R34-12-20210131","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1128\/IAI.72.7.4159-4171.2004","article-title":"Characterization of beta-glucan recognition site on C-type lectin, dectin 1.","volume":"72","author":"Adachi","year":"2004","journal-title":"Infect Immun"},{"key":"R35-12-20210131","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/01.qai.0000225011.76439.99","article-title":"Assessment of the association between HIV viral load and CD4 cell count on the occurrence of oropharyngeal candidiasis in HIV-infected patients.","volume":"42","author":"Mercante","year":"2006","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201009010-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:30:29Z","timestamp":1786041029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201009010-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181e53c64","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,1]]}}}